Health Care & Life Sciences

FDA’s $6.4B drug review-fee plan passes Senate

May 24, 2012
Bloomberg News
The U.S. Senate voted to let regulators collect on a $6.4 billion fee agreement struck with Indianapolis-based Eli Lilly and Co., Medtronic Inc. and other companies to fund reviews of new drugs and medical devices through 2017.
More

Local WellPoint unit eliminating 112 employees

May 23, 2012
National Government Services Inc., which processes Medicare and Medicaid claims for the federal government, attributed the job reductions to the loss of a government contract. The subsidiary will still have about 500 workers in Indianapolis.
More

Howard officials OK hospital merger with Community

May 23, 2012
J.K. Wall
The merger of Kokomo’s Howard Regional Health System into Indianapolis-based Community Health Network received final approval Tuesday night.
More

Q&A

May 21, 2012
J.K. Wall

Since its acquisition last year by Florida-based AssuredPartners Inc., the Indiana operations of Neace Lukens has been looking more aggressively to acquire smaller benefits brokers. In the past month, Neace Lukens has announced deals to buy Benefit Concepts, a six-person benefits consultancy in Indianapolis, and Matrix Benefits and Consulting Group, a one-person benefits shop in Fort Wayne. Eric Chelovitz, managing director of Neace Lukens’ 34-person Indianapolis office, said he expects more consolidation in the industry.

More

IU Health will refund $280,000 to Medicare

May 21, 2012
J.K. Wall
Indiana University Health will refund the federal Medicare program $280,000 after an audit of almost 200 claims made by its downtown hospitals found nearly 18 percent of them had been billed improperly.
More

Potential Effient rival recommended for approval

May 21, 2012
Bloomberg News
Johnson & Johnson and Bayer AG’s blood-thinner Xarelto should be approved to help prevent heart attacks and strokes in patients with a common condition, a U.S. regulatory report recommended.
More

Price pressures could ground Lilly's growth

May 21, 2012
J.K. Wall

Most analysts agree with Eli Lilly and Co.’s prediction that, after tough years from 2012 to 2014, the drugmaker will begin growing sales and profits again. But in a new report, BMO Capital Markets predicts Lilly will get stuck at a reduced level of revenue and profit in 2014 and stay there for years.

More

Good cholesterol may not lower heart risk, study suggests

May 17, 2012
Bloomberg News
Raising good cholesterol, a goal pursued by Eli Lilly and Co. as the next milestone in cardiac care, may not cut heart-attack risk, says a study that challenges the development of drugs that may someday generate billions of dollars in sales.
More

U.S. losing drug-research jobs to other countries

May 17, 2012
Bloomberg News
Eli Lilly and other big pharmaceutical companies are creating thousands of research jobs overseas as countries led by Singapore, Ireland and South Africa boost incentives.
More

Lilly unlikely to gain from Plavix patent loss, analyst says

May 17, 2012
Bloomberg News
Indianapolis-based Eli Lilly and Co. and London-based AstraZeneca Plc aren't expected to have an easier time gaining more of the market for blood thinners dominated by Bristol-Myers Squibb Co.’s Plavix after the drug loses U.S. patent protection Thursday.
More

WellPoint protestors harass Braly as political disclosure proposal fails

May 16, 2012
J.K. Wall
The proposal, which sought twice-yearly reports on all the health insurer's donations used for political campaigns or lobbying, was overwhelmingly voted down by WellPoint shareholders.
More

Activists plan to protest WellPoint political giving at meeting

May 15, 2012
J.K. Wall
A mix of union groups, activist investors and single-payer advocates will call for increased disclosure from WellPoint, and some investment funds will vote against WellPoint board members who they say have failed to exercise proper oversight of WellPoint’s political spending.
More

Indiana slips in life sciences funding

May 14, 2012
J.K. Wall
Indiana has taken “a giant step backward” in the availability of early-stage capital for life sciences companies, according to the Indiana Health Industry Forum—which also has a few ideas on how to reverse those developments.
More

Justices grill both sides in IU Health case

May 14, 2012
J.K. Wall
Much of the nearly 45 minutes of arguments and questioning on May 10 involved the justices and the lawyers for both parties trying unsuccessfully to apply various scenarios from the retail world of commerce to health care pricing.
More

More physicians using social media to find jobsRestricted Content

May 12, 2012
Scott Olson
But major Indianapolis-area hospitals still prefer personal referrals
More

TITTLE: Big challenges loom for nursing facilitiesRestricted Content

May 12, 2012
Scott Tittle / Special to IBJ
Boom in elderly population and falling reimbursements expected to cause squeeze.
More

OBEIME: Poor, uninsured won't monopolize resourcesRestricted Content

May 12, 2012
Myth prevents policymakers from attacking real problem of distributing funding.
More

SCHREIBER: Innovation will drive health care industryRestricted Content

May 12, 2012
Entrepreneurship needs broader encouragement, and is targeted in a new plan.
More

Companies adopting unlimited time-off policiesRestricted Content

May 12, 2012
J.K. Wall
Proponents of such policies say they are the future of work—even as they acknowledge that it may take a generation for them to be widely accepted. Some workers, however, are fearful.
More

Purdue looks to new clinic to cut health costs

May 11, 2012
Associated Press
Purdue University's trustees approved plans Friday for a new campus medical clinic that administrators expect eventually will cut the school's health care costs for employees and their families.
More

Roche scraps hoped-for cholesterol blockbuster

May 7, 2012
Associated Press
A second experimental cholesterol medicine in a once-promising class of drugs meant to replace blockbusters such as Lipitor has failed in testing, casting doubt on whether any of the drugs will ever make it to pharmacies. Eli Lilly is developing a similar drug.
More

Lilly: Forget Alzheimer's; think diabetes

May 7, 2012
J.K. Wall
For more than a year, Eli Lilly and Co. has been viewed by investors as a laggard stock with one, slim shot at producing a huge jackpot: its experimental Alzheimer’s drug. But now company leaders are trying to direct investor attention toward the drugmaker’s diabetes portfolio.
More

State's high court to weigh hospital bills

May 7, 2012
J.K. Wall
The Indiana Supreme Court this week will consider whether hospital billing practices should be put on trial. The state’s highest court will hear oral arguments Thursday in a case in which two uninsured patients have sued Indiana University Health for charging them much higher prices than it would have charged insured patients.
More

Q&A

May 7, 2012
J.K. Wall
Dr. Malaz Boustani, the medical director of Wishard Health Services’ Healthy Aging Brain Center, thinks pop-up alerts for physicians that are part of many electronic medical record and e-prescribing systems are ineffective and need to be re-engineered.
More

Set pricing helps boost diagnostic network's growthRestricted Content

May 5, 2012
J.K. Wall
When the same MRI at one facility costs $600 and at another costs $2,200, Dr. Robert Gregori would call that a business opportunity.
More
Page  1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. we love that we were right in our predictions for the outcome of Tony's boondoggle. We aren't negative, we are positive that the league that never has will continue to blow chunks and stink up the place

  2. I was initially excited to learn that this wasn't rubber-stamped, but if all that is required is to add some shrubs and some "window dressing" over the first floor of the garage, then I'd call it a waste of everyone's time. It should be noted that the Hearing Examiner is a DMD employee who reports to the same administrator as the DMD staff planner who recommended approval of the garage and whose report said that the requirement for ground-floor retail had been "satisfied". Better luck with appealing the inevitable approval at the MDC, where the commissioners are appointed by the Mayor, City Council, and County Commissioners, thus, presumably not all obligated to facilitate the administration's plans.

  3. Wheat Thins, when paired with chocolate ice cream!

  4. About the same.

  5. New airport, new Lucas Oil Stadium, expanded convention center, $30,000,000 Pacer gift, Stupid City Way Project, Broad Ripple Parking Garage $ Giveaway, Money blown on lethal bike lanes. The list is endless..

    We have complete morons in City Government with grafter buddies sitting in the wings also stealing parking meter revenue. Go to
    www.adavceindiana.com and read about Chicago Parking Meter Corruption.

    It's all theft of taxpayer resources and complete lack of financial stewardship and devoid of integrity.

    I would just like for basic city services please.

ADVERTISEMENT